Results 11 to 20 of about 1,085,609 (304)
Survey and analysis of the availability and affordability of essential drugs in Hefei based on WHO / HAI standard survey methods [PDF]
BMC Public Health, 2020 Background The 2018 edition of the National Essential drugs List came into effect in September 2018. Relevant policies require that all primary medical and health institutions should supply national essential drugs, while secondary and tertiary medical ...
Zuojun Dong, Qiucheng Tao, Guojun Sun
doaj +2 more sources
Digital transformation, green finance, and pharmaceutical affordability in China: a health economics perspective [PDF]
Frontiers in Public HealthIntroductionDrug accessibility is a core challenge facing global public health systems, with financing costs directly affecting drug prices through cost-plus pricing mechanisms.
Jingdong Huang, Xinyi Zhang
doaj +2 more sources
Annals of Medicine, 1993 Availability of an appropriate selection and regular supply of affordable drugs that are efficacious, safe and of good quality, is a prerequisite for any operative health care system. In most of the industrialized countries a variety of drugs are usually available in sufficient quantity and some drugs may even be over-used in medical therapy, yet half ...
exaly +3 more sources
Are drugs for rare diseases "essential"?
Bulletin of the World Health Organization, 2006 In 1977, the first report of the WHO Expert Committee on the Use of Essential Drugs defined essential drugs as those needed to satisfy the health-care needs of the majority of the population. This was done in order to fulfil a mandate to assist Member States in selecting and obtaining essential medicaments for their populations.
Marcus M Reidenberg
doaj +3 more sources
Rare essentials: drugs for rare diseases as essential medicines
Bulletin of the World Health Organization, 2006 Since 1977, the WHO Model List of Essential Medicines (EML), published by WHO, has provided advice for Member States that struggle to decide which pharmaceutical technologies should be provided to patients within their public health systems.
Pieter Stolk +2 more
doaj +5 more sources
PROCUREMENT OF ESSENTIAL DRUGS
Ethiopian Journal of Health Development, 2017 INTRODUCTION1985 commemorated the tenth anniversary of the idea of essential drugs. It was in 1975 that the WHO Director General outlined possible new drug policies (1), and the World Health Assembly requested that advice be given to Member States on the selection and procurement of essential drugs (2).
Tadeusz J Szuba
openaire +3 more sources
Essential Drugs – Whose Responsibility? [PDF]
Journal of the Royal Society of Medicine, 1981 Antezana, F.S
openaire +3 more sources
A third-line antiretroviral therapy register to track patient clinical and virological outcomes
South African Medical Journal, 2022 -
K Naidoo +3 more
doaj +1 more source
Journal of Nature and Science of Medicine, 2022 Background: Implications from accumulated bodies of commentaries and media/social-media reports highlight the drug shortage during the COVID-19 pandemic. In this special report, the relation between drug shortage and response measures is discussed in the
Mohammed Salahuddin +4 more
doaj +1 more source
Health Systems & Reform, 2021 Evidence shows that those with non-communicable diseases (NCDs) are at higher risk for serious illness and mortality from COVID-19. In Kenya, about 50% of the COVID-19 patients who have died had an NCD.
Zana Wangari Kiragu +9 more
doaj +1 more source